These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 890692)

  • 1. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.
    Kamalakar P; Freeman AI; Higby DJ; Wallace HJ; Sinks LF
    Cancer Treat Rep; 1977 Aug; 61(5):835-9. PubMed ID: 890692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.
    Ochs JJ; Freeman AI; Douglass HO; Higby DS; Mindell ER; Sinks LF
    Cancer Treat Rep; 1978 Feb; 62(2):239-45. PubMed ID: 346212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cis-Dichlorodiammineplatinum(II) in childhood cancer.
    Freeman AI; Ettinger LJ; Brecher ML
    Cancer Treat Rep; 1979; 63(9-10):1615-20. PubMed ID: 291483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusion.
    Salem P; Hall SW; Benjamin RS; Murphy WK; Wharton JT; Bodey GP
    Cancer Treat Rep; 1978 Oct; 62(10):1553-5. PubMed ID: 361227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies.
    Vietti TJ; Nitschke R; Starling KA; van Eys J
    Cancer Treat Rep; 1979; 63(9-10):1611-4. PubMed ID: 291482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of cis-DDP in children with refractory malignant tumors].
    Nakadate H; Kobayashi R; Nishi M; Hatae Y; Takeda T; Uchino J; Hirama T; Kobayashi H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):598-603. PubMed ID: 3954383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cis-platinum in neuroblastoma].
    Nakadate H; Nishi M; Hattori T; Hatae Y; Takeda T
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):147-50. PubMed ID: 4038446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).
    ; Villablanca JG; Krailo MD; Ames MM; Reid JM; Reaman GH; Reynolds CP
    J Clin Oncol; 2006 Jul; 24(21):3423-30. PubMed ID: 16849757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.
    Pratt CB; Hayes A; Green AA; Evans WE; Senzer N; Howarth CB; Ransom JL; Crom W
    Cancer Treat Rep; 1981; 65(11-12):1021-6. PubMed ID: 7197583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.
    Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
    Cancer Treat Rep; 1981; 65(9-10):815-22. PubMed ID: 6944156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.
    Chary KK; Higby DJ; Henderson ES; Swinerton KD
    Cancer Treat Rep; 1977; 61(3):367-70. PubMed ID: 266972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.
    Wiltshaw E; Kroner T
    Cancer Treat Rep; 1976 Jan; 60(1):55-60. PubMed ID: 1000519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
    Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase I study of a new antineoplastic agent, cis-diamminedichloroplatinum (II)].
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):38-45. PubMed ID: 6892190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of carboplatin (CBDCA) in children with cancer.
    Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
    Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase II study of cis-dichlorodiammineplatinum (II) for non-small cell lung cancer].
    Fukuoka M; Furuse K; Takada M; Negoro S; Tamai S; Matsui K; Sakai N; Ryu S; Yoshinaga T; Kawahara M
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):471-8. PubMed ID: 2988455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer.
    Yap HY; Salem P; Hortobagyi GN; Bodey GP; Buzdar AU; Tashima CK; Blumenschein GR
    Cancer Treat Rep; 1978 Mar; 62(3):405-8. PubMed ID: 348308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study.
    Rossof AH; Coltman CA; Jones SE; Talley RW
    Cancer Treat Rep; 1979; 63(9-10):1605-8. PubMed ID: 498159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.